BIC
TEVA icon

Beach Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Beach Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,936
Closed -$53K – 203
2024
Q3 		$53K Hold
2,936
– – 0.01% 177
2024
Q2 		$48K Buy
+2,936
New +$45.2K 0.01% 180

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Beach Investment Counsel's TEVA Position: Q4 2024 in Review

Beach Investment Counsel sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 2,936 shares — an estimated $53K sold.

Beach Investment Counsel first reported a position in TEVA in Q2 2024 and held it in 2 quarters. The position peaked at $53K in Q3 2024. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Beach Investment Counsel reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Beach Investment Counsel sold 2,936 Teva Pharmaceuticals shares in Q4 2024, an estimated $53K.
  • Beach Investment Counsel first reported a position in Teva Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • Beach Investment Counsel's Teva Pharmaceuticals position peaked at $53K in Q3 2024.
  • 584 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Beach Investment Counsel's 13F filing for Q4 2024, filed 27 Jan 2025.